proliferate and differentiate bone building cells.
This bioactive technology platform is only available
through NovaBone.
NovaBone's bone graft substitute is engineered to accelerate the body’s natural
healing process with a measured release of ions and changes in surface chemistry that supercharge cellular activity with preferential development of cells that form new bone.
The FDA authorized our use of the term osteostimulation to define this
unique process.
Numerous studies, including human clinical trials, have proven that NovaBone demonstrates equivalent rates of bone growth when compared to autogenous
bone graft.
